Kind Consumer Holdings Limited has secured funding for the manufacture and marketing of the shelved medically regulated nicotine inhaler Voke in the United Kingdom, the company said in a press release.

The unspecified amount of funds raised will be used to complete manufacturing capacity for the device, and to begin recruiting marketing personnel ahead of a UK market launch slated for 2019, the company said.
“This funding is another step towards commercialisation of Voke, a product which promises to make a real difference to the health burden of smoking by offering an alternative to smoking for smokers and those around them,” Paul Triniman, CEO of Kind Consumer Holdings, was quoted as saying.
Voke was granted a medicinal product licence in September 2014 from the UK Medicines and Healthcare products Regulatory Agency. Issues concerning the manufacture of the nicotine inhaler had delayed its launch and UK company, Kind Consumer Holdings, assumed full responsibility for making the device in January 2017, according to the press release.